{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:53:06Z","timestamp":1772941986652,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Novartis"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Breast cancer (BC) is the most common malignancy among Brazilian women, with a high percentage of the cases diagnosed at advanced or metastatic stages (mBC). In Brazil, where 75% of the population depends on the resource-limited public health system (SUS), mBC poses significant treatment challenges and disparities. To characterize this scenario, we conducted an online survey assessing treatment strategies available for HER2-negative, hormone receptor (HR)-positive mBC across public and private health systems. The 48-question survey addressed topics such as waiting time (WT) from oncology unit entry to treatment initiation, availability of oncologic medications, and access to palliative and multidisciplinary care teams. Between 2 August 2022 and 30 September 2022, a total of 180 oncologists were invited, and 150 met the inclusion criteria. The median WT for surgery was 60 days in the SUS versus 30 days in the private sector (p &lt; 0.0001), and for chemotherapy, 30 days in the SUS versus 15 days privately (p &lt; 0.0001). Endocrine therapy was the preferred first-line treatment in the SUS (83.3%), while fulvestrant was available to only 48% of respondents. Additionally, specialized palliative care teams were available according to 66% of SUS respondents compared with 82% in the private system (p = 0.001). These findings underscore persistent disparities in mBC treatment, likely driven by limited governmental health investment.<\/jats:p>","DOI":"10.3390\/curroncol32080471","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:59:01Z","timestamp":1755601141000},"page":"471","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil"],"prefix":"10.3390","volume":"32","author":[{"given":"Heloisa","family":"Resende","sequence":"first","affiliation":[{"name":"Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil"},{"name":"Instituto Projeto CURA, S\u00e3o Paulo 05507-020, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vin\u00edcius de Q.","family":"Aguiar","sequence":"additional","affiliation":[{"name":"Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataline F. de A.","family":"Santos","sequence":"additional","affiliation":[{"name":"Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3329-4991","authenticated-orcid":false,"given":"Jo\u00e3o Vitor Siqueira","family":"Jardim","sequence":"additional","affiliation":[{"name":"Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3019-2687","authenticated-orcid":false,"given":"Andr\u00e9","family":"Ornelas","sequence":"additional","affiliation":[{"name":"Novartis Brazil, S\u00e3o Paulo 04706-900, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"de C\u00e2ncer, I.N. (2023). Estimativa 2023: Incid\u00eancia de C\u00e2ncer no Brasil, Instituto Nacional De C\u00e2ncer.","DOI":"10.32635\/2176-9745.RBC.2000v46n1.3398"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10549-020-05831-y","article-title":"The Impact of Sociodemographic Factors and Health Insurance Coverage in the Diagnosis and Clinicopathological Characteristics of Breast Cancer in Brazil: AMAZONA III Study (GBECAM 0115)","volume":"183","author":"Rosa","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Werutsky, G., Rosa, D.D., Reinert, T., Barroso-Sousa, R., Resende, H., Signorini, P., Cronemberger, E., Fagundes, J.G.M., Leal, J.H.S., and Guimar\u00e3es, M.B. (2025). Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study). Clin. Breast Cancer, S1526820925001624.","DOI":"10.1016\/j.clbc.2025.05.020"},{"key":"ref_5","first-page":"100028","article-title":"Practical Considerations for Expediting Breast Cancer Treatment in Brazil","volume":"2","author":"Bretas","year":"2021","journal-title":"Lancet Reg. Health\u2014Am."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1200\/GO.20.00566","article-title":"Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies","volume":"7","author":"Barrios","year":"2021","journal-title":"JCO Glob. Oncol."},{"key":"ref_7","unstructured":"Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) (2025). General Data Beneficiaries of Private Health Plans, by Assistance Coverage (Brasil\u20142015\u20132025), Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS)."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.arcmed.2022.11.013","article-title":"Socioeconomic Impact of Cancer in Latin America and The Caribbean","volume":"53","author":"Werutsky","year":"2022","journal-title":"Arch. Med. Res."},{"key":"ref_9","unstructured":"Collor, F., and Guerra, A. (2025, August 01). Law No. 8080, of 19 September 1990, Available online: https:\/\/www.planalto.gov.br\/ccivil_03\/leis\/l8080.htm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(19)31243-7","article-title":"Brazil\u2019s Unified Health System: The First 30 Years and Prospects for the Future","volume":"394","author":"Castro","year":"2019","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Andrade, D.A.P., Veneziani, A.C., Paiva, C.E., Reis, R.D., Filho, C.A.F., Sanches, A.O.N., Barroso, A.W.A., Paz, A.C.M.C., Kons, G.C.D.M., and Preto, D.D. (2023). Discrepancies in Breast Cancer\u2019s Oncological Outcomes between Public and Private Institutions in the Southeast Region of Brazil: A Retrospective Cohort Study. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1169982"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.32635\/2176-9745.RBC.2018v64n2.83","article-title":"A Assist\u00eancia Oncol\u00f3gica e Os 30 Anos Do Sistema \u00danico de Sa\u00fade","volume":"64","author":"Gadelha","year":"2019","journal-title":"Rev. Bras. Cancerol."},{"key":"ref_13","unstructured":"Serra, J. (2025, August 01). Ordinance No. 3535 of 2 September 1998, Available online: https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/gm\/1998\/prt3535_02_09_1998_revog.html."},{"key":"ref_14","unstructured":"Serra, J. (2025, August 01). Ordinance No. 3536, of 2 September 1998, Available online: https:\/\/pesquisa.in.gov.br\/imprensa\/jsp\/visualiza\/index.jsp?data=03\/09\/1998&jornal=1&pagina=167&totalArquivos=202."},{"key":"ref_15","unstructured":"Temporao, J.G. (2025, August 01). Ordinance No. 741 of 19 December 2005, Available online: https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/sas\/2005\/prt0741_19_12_2005.html."},{"key":"ref_16","unstructured":"Rousseff, D., Mantega, G., and Padilha, A.R.S. (2025, August 01). Law No. 12401, of 28 April 2011, Available online: https:\/\/www.planalto.gov.br\/ccivil_03\/_ato2011-2014\/2011\/lei\/l12401.htm."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Barreto, M.L., Rasella, D., Machado, D.B., Aquino, R., Lima, D., Garcia, L.P., Boing, A.C., Santos, J., Escalante, J., and Aquino, E.M.L. (2014). Monitoring and Evaluating Progress towards Universal Health Coverage in Brazil. PLoS Med., 11.","DOI":"10.1371\/journal.pmed.1001692"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41571-022-00700-7","article-title":"Barriers in Access to Oncology Drugs\u2014A Global Crisis","volume":"20","author":"Barrios","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_19","unstructured":"CFM-DF (2018). Demografia M\u00e9dica no Brasil 2018, CFM-DF."},{"key":"ref_20","unstructured":"Rousseff, D., Cardozo, J.E., and Padilha, A.R.S. (2025, August 01). Law No. 12732 of 22 November 2012, Available online: http:\/\/www.planalto.gov.br\/ccivil_03\/_ato2011-2014\/2012\/lei\/l12732.htm."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Resende, H., Aguiar, V., Jacob, L., Ren\u00f3, A., Cunha, A., Assis, B., Pereira, V., Tureta, L., Eler, L., and Oliveira, M. (2023). The Journey of Breast Cancer Patient from Self-Perception of Breast Abnormalities to First Cancer Treatment\u2014A Sectional Study in Sul Fluminense Region-RJ-Brazil. Med. Res. Arch., 11.","DOI":"10.18103\/mra.v11i10.4577"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ferreira, N.A.S., Schoueri, J.H.M., Sorpreso, I.C.E., Adami, F., and Dos Santos Figueiredo, F.W. (2020). Waiting Time between Breast Cancer Diagnosis and Treatment in Brazilian Women: An Analysis of Cases from 1998 to 2012. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17114030"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/03630242.2021.1927285","article-title":"Analysis of the Waiting Time of the Diagnosis for the First Breast Cancer Treatment in Southern Brazil","volume":"61","author":"Jobim","year":"2021","journal-title":"Women Health"},{"key":"ref_24","unstructured":"Ceschin, M. (2025, August 01). Normative Resolution No. 259, of 17 June 2011, Available online: https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/ans\/2011\/res0259_17_06_2011.htm."},{"key":"ref_25","unstructured":"Mosconi, C.E.V. (2025, August 01). Ordinance No. 171 of 17 December 1993. Available online: http:\/\/www.oncoguia.org.br\/pub\/15_oncoguia_noticias\/Portaria_171.pdf."},{"key":"ref_26","unstructured":"Mosconi, C.E.V. (2025, August 01). Ordinance No. 170 of 17 December 1993. Available online: http:\/\/www.oncoguia.org.br\/pub\/15_oncoguia_noticias\/Portaria_170.pdf."},{"key":"ref_27","unstructured":"Padilha, A.R.S. (2025, August 01). Ordinance No. 2947 of 21 December 2012, Available online: https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/gm\/2012\/prt2947_21_12_2012.html."},{"key":"ref_28","unstructured":"SIASUS (2025, August 01). Sistema de Informa\u00e7\u00f5es Ambulatoriais Do SUS, Available online: http:\/\/sia.datasus.gov.br\/documentos\/listar_ftp_apac.php."},{"key":"ref_29","unstructured":"(2025, August 01). Minist\u00e9rio da Sa\u00fade Manual de Bases T\u00e9cnicas Da Oncologia\u2014Sistema de Informa\u00e7\u00f5es Ambulatoriais (SIA\/SUS), 30a Edi\u00e7\u00e3o 2022, Available online: https:\/\/www.inca.gov.br\/sites\/ufu.sti.inca.local\/files\/\/media\/document\/\/manual_oncologia_30a_edicao_agosto_2022_25_08_2022_-_26-08-2022.pdf."},{"key":"ref_30","unstructured":"Editora Atheneu (2021). Manual de Condutas em Oncologia, Editora Atheneu."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2016.67.1487","article-title":"Endocrine Therapy for Hormone Receptor\u2013Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline","volume":"34","author":"Rugo","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_32","unstructured":"Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade\u2014CONITEC (2021). Abemaciclibe, Palbociclibe e Succinato de Ribociclibe Para o Tratamento de Pacientes Adultas Com C\u00e2ncer de Mama Avan\u00e7ado Ou Metast\u00e1tico Com HR+ e HER2, CONITEC."},{"key":"ref_33","unstructured":"(2025, August 01). Sociedade Brasileira de Oncologia Cl\u00ednica (SBOC) Proposta SBOC Para Garantir o Efetivo Acesso a Antineopl\u00e1sicos Incorporados Ao SUS 2023. Available online: https:\/\/sboc.org.br\/images\/pdf\/075-Proposta-SBOC-Iniquidade-Pos-Conferencia.pdf."},{"key":"ref_34","unstructured":"Gadelha, C.A.G. (2025, August 01). Ordinance No. 18 of 25 July 2012, Available online: https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/sctie\/2012\/prt0018_25_07_2012.html."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMp2202098","article-title":"Access to Biomedical Innovation\u2014Inside the Legal Labyrinth","volume":"388","author":"Rai","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Dos Santos, R.L.B., Pepe, V.L.E., and Osorio-de-Castro, C.G.S. (2022). Public Procurement of Antineoplastic Agents Used for Treating Breast Cancer in Brazil between 2013 and 2019. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09851-3"},{"key":"ref_37","first-page":"e20240203","article-title":"Financial Impact of Centralized Purchasing of Rituximab by the Brazilian Ministry of Health for Lymphoma Treatment, 2015\u20132022: An Exploratory Study","volume":"34","author":"Martins","year":"2025","journal-title":"Epidemiol. Serv. Sa\u00fade"},{"key":"ref_38","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA) (2025, August 01). Listas de Pre\u00e7os de Medicamentos\u2014CMED, Available online: https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/medicamentos\/cmed\/precos\/capa-listas-de-precos."},{"key":"ref_39","unstructured":"Okane, S.Y. (2025, August 01). Ordinance No. 2, of 3 January 2022, Available online: https:\/\/www.in.gov.br\/en\/web\/dou\/-\/portaria-n-2-de-3-de-janeiro-de-2022-371727353."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1200\/GO.20.00081","article-title":"ABC4 Consensus: First Latin American Meeting\u2014Assessment, Comments, and Application of Its Recommendations","volume":"6","author":"Gomez","year":"2020","journal-title":"JCO Glob. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S2214-109X(24)00534-5","article-title":"Cancer Plans Should Consider Local Needs","volume":"13","author":"Murillo","year":"2025","journal-title":"Lancet Glob. Health"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"OECD (2021). OECD Reviews of Health Systems: Brazil 2021, OECD. OECD Reviews of Health Systems.","DOI":"10.1787\/146d0dea-en"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"OECD (2025). Institutionalising Health Accounts in Brazil: A Review of Methods, Data and Policy Relevance, OECD Publishing. OECD Reviews of Health Systems.","DOI":"10.1787\/b6d405f9-en"},{"key":"ref_44","unstructured":"Organisation for Economic Co-operation and Development (OECD) OECD (2025, August 01). Stat Database. Available online: https:\/\/stats.oecd.org\/."},{"key":"ref_45","unstructured":"OECD, and The World Bank (2023). Health at a Glance: Latin America and the Caribbean 2023, OECD."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1470-2045(13)70048-2","article-title":"Planning Cancer Control in Latin America and the Caribbean","volume":"14","author":"Goss","year":"2013","journal-title":"Lancet Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/8\/471\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:30:38Z","timestamp":1760034638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/8\/471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["curroncol32080471"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32080471","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}